Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
WASHINGTON–(BUSINESS WIRE)–#AR—Altoida, Inc., the precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced that management will be presenting at the upcoming conferences:
Panel Title: New Diagnostics: Revolutionizing Care in Alzheimer’s
Date/Time: Wednesday, Nov. 9, 10:30 – 11:30 am ET
Location: Lotte Palace Hotel, New York, NY
Date: Nov. 13-16, 2022
Location: Kiosk #1158-20, UCSF HealthHub Pavilion, Level 2 show floor, The Venetian Expo & Convention Center, Las Vegas, NV
Panel Title: Digital Phenotypes of Brain Diseases – Transforming Alzheimer’s Disease Drug Development and Disease Management
Date/Time: Saturday, November 19, 1:00 -1:50 pm ET
Location: The Boca Raton, 501 East Camino Real, Boca Raton, FL
Microsoft Data Science & Law Forum
Keynote Title: Transforming patient’s management and clinical development via AI driven precision medicine.
Keynote Speaker: Dr. Antonella Santuccione Chadha, Chief Medical Officer, Altoida
Date: Wednesday, Nov. 23
Location: Brussels, Microsoft HQ
Round table: The Alzheimer’s disease Patient Pathway from a sex and gender lens.
Speaker: Dr. Antonella Santuccione Chadha
Date: Nov. 29 – Dec 2.
Location: Hilton Union Square, San Francisco, CA
Roche Start Up Day
Date: Thursday, Nov. 10
Location: Roche HQ, Basel, Switzerland
Speaker: Dr. Antonella Santuccione Chadha
Digital Phenotypes of Brain Diseases – Transforming neuroscience clinical development
HBA Roche Event
Round table: The missing X
Speaker: Dr. Antonella Santuccione Chadha
Date: Tuesday, Dec. 6
Location: Basel, Roche HQ Switzerland
To meet with the Altoida team at these events, contact bd@altoida.com.
About Altoida, Inc.
Altoida is pioneering precision neurology diagnostics to set a new gold standard for patient care. Our innovative AI-driven approach combines novel digital biomarkers with immersive augmented reality to evaluate cognition. The result is our validated device and evidence-based platform with more than 20 years of scientific research. Altoida is based in Washington, DC. For more information, visit www.altoida.com or follow @Altoida on Twitter.
Contacts
Media
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com
The new OP03021 full-color sequential LCOS panel is the only solution available on the market…
Nation's Leading All-Inclusive Wedding Venue Brand Grows Portfolio to Over 80 Venues Across Nine States…
Many taxpayers mistakenly believe an extension pauses IRS penalties and interest. Experts say that misunderstanding…
Powering the AI Financial Infrastructure Layer Behind Global Platforms, Marketplaces, and Digital Services PALO ALTO,…
AI assisted Health Cube open to patients in Guardia Perticara (Basilicata), Italy VANCOUVER, BC /…
MIAMI, FL / ACCESS Newswire / December 17, 2025 / KIFFIK Biomedical announced today the…